Cost-effectiveness of dapagliflozin for the treatment of chronic kidney disease: a systematic review

Authors

Institutions

Publication Details

Journal
Cost Effectiveness and Resource Allocation
Published
2026-10-06
DOI
https://doi.org/10.1186/s12962-026-00817-x
Primary Topic
Health Systems, Economic Evaluations, Quality of Life
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cost-effectiveness of dapagliflozin for the treatment of chronic kidney disease: a systematic review

Nannan Yan, Jun Zhang, Zehui Jiang, Dongxiao Chen et al.
Cost Effectiveness and Resource Allocation
Health Systems, Economic Evaluations, Quality of Life
article

Cost-effectiveness of dapagliflozin for the treatment of chronic kidney disease: a systematic review

Nannan Yan, Jun Zhang, Zehui Jiang, Dongxiao Chen, Fei Le, Cai Xiao
article en

Abstract

No abstract available for this paper.
Cost Effectiveness and Resource Allocation
Jiangxi University of Traditional Chinese Medicine (CN), People's Liberation Army 401 Hospital (CN)
Openalex Percentile: Top 7%
Health Systems, Economic Evaluations, Quality of Life
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Cost-effectiveness of dapagliflozin for the treatment of chronic kidney disease: a systematic review — Nannan Yan, Jun Zhang, et al. · Cost Effectiveness and Resource Allocation (2026) | TGRS Research Map | TGRS